Prof Samuel C Dudley, MD, PhD, FACP, FACC is an expert in Cardiology at University of Minnesota (United States). Samuel C Dudley has authored 294 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 1,531 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Samuel C Dudley, MD, PhD, FACP, FACC University of Minnesota United States
1 531 ScienceLeadR Reputation 1531
Network Map

Cardiology

Subspecialties: Genetics - Nutrition - Histology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr. Dudley is a physician scientist and Professor of Medicine at the Lillehei Heart Institute (LHI) of the University of Minnesota. He was a Chief of Cardiology in three Universities over 22 years and the former Director of the LHI. He is a Fellow of the American College of Cardiology and American Heart Association, Editorial Board member for the Journal of the American College of Cardiology, and a member of the Association of University Cardiologists and the American Society for Clinical Investigation. He is the founder of Diastol, a company commercializing treatments for heart failure with preserved ejection fraction. His research program focuses on inflammation and its effects on arrhythmia and diastolic heart failure. He has submitted more than 30 patent applications on new diagnostics and therapeutics in these areas.


Organizations

Career arc: 1990 - 2026
Source: PubMed

University of Minnesota

2018 - 2026

Heart Institute

2022 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 294

Citations

Citations: 11 255 1st author: 11 Last author: 180 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
NIMA-Related Kinase-7 Activates Atrial Cardiomyocyte NLRP3 Inflammasome and Associates With Occurrence of Postoperative Atrial Fibrillation.
PMID 42841201 — hypertension, hyperlipidemias, coronary artery disease, arrhythmias, cardiac, inflammasomes, nima-related kinases, atrial fibrillation, myocytes, cardiac
Circ Arrhythm Electrophysiol20260
Cardiac Sodium Channel Regulation: A Potential New Therapeutic Target in Cardiomyopathy.
PMID 42024714 — heart failure, arrhythmias, cardiac, cardiovascular system, mitochondria, ion channels, therapeutics, sodium channels, cardiomyopathies
Circ Res20260
Stress-Induced Down-Regulation of CPEB4 Disrupts Sodium Channel Regulation and Myocardial Excitability.
PMID 41846068 — polyadenylation, heart failure, heart, arrhythmias, cardiac, stress, physiological, ion channels, down-regulation, sodium channels
JACC Basic Transl Sci20260
Large-Scale Proteomic Profiling of Incident Heart Failure and Its Subtypes in Older Adults.
PMID 41636061 — genes, myocardial infarction, heart failure, heart, cardiovascular diseases, heart failure, diastolic, heart failure, systolic, proteomics, therapeutics, random allocation, complement c9
Circ Genom Precis Med20260
Type 1 diabetes mellitus and atrial fibrillation - clinical relationships, mechanistic insights and therapeutic implications.
PMID 41296793 — diabetes mellitus, atrial fibrillation, risk factors, therapeutics, diabetes mellitus, type 1
Cardiovasc Res20250

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6

By phase:

N/A 6
Phase 1 1
Phase 2 1
Phase 3 1

By status:

Terminated 5
Completed 4

By type:

Observational 6
Interventional 3

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 6
multicentric5to9 1
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map